Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic

Hidenori Toyoda, Daniel Q. Huang, Michael H. Le, Mindie H. Nguyen – 17 July 2020 – As social distancing and strict stay‐at‐home orders have been instituted to slow the spread of coronavirus disease 2019 (COVID‐19), unintentional outcomes among those with chronic diseases including screening for the lethal hepatocellular carcinoma (HCC) may be occurring. We aimed to describe the changes in liver care before and after COVID‐19 restricted access to health care.

Natural Course of Pediatric Portal Hypertension

Al‐Faraaz Kassam, Gillian R. Goddard, Michael E. Johnston, Alexander R. Cortez, Andrew T. Trout, Todd M. Jenkins, Alexander G. Miethke, Kathleen M. Campbell, Jorge A. Bezerra, William F. Balistreri, Jaimie D. Nathan, Maria H. Alonso, Gregory M. Tiao, Alexander J. Bondoc – 16 July 2020 – The etiology of portal hypertension (pHTN) in children differs from that of adults and may require different management strategies. We set out to review the etiology, management, and natural history of pHTN at a pediatric liver center.

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

Georg Semmler, Teresa Binter, Karin Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, Sabrina Gavasso, David Chromy, David J.M. Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa Bucsics, Albert F. Stättermayer, Matthias Pinter, Petra Steindl‐Munda, Rainer Schöfl, Francesco Paolo Russo, Paolo Simioni, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer – 13 July 2020

Subscribe to